James Owens
Known title: President and CEOCIK: 0001443909
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
H.B. Fuller prices $850 million senior notes offering. H.B. Fuller has priced an $850 million senior notes offering, a move that adds to the company's debt load. The stock is currently trading near the lower end of its 52-week range, with an RSI of 41.5 indicating moderate weakness. This capital raise provides context for investors monitoring the company's financial structure alongside its recent price action.
Transaction History
| DCI | ▲ Buy | Grant | 267 | $24K | 7/3/2026 | View on chart |
| DCI | ▲ Buy | Option Exercise | 7,153 | $302K | 4/14/2026 | View on chart |
| DCI | ▼ Sell | Open Market | 7,153 | $638K | 4/14/2026 | View on chart |
| DCI | ▲ Buy | Option Exercise | 6,600 | $323K | 4/14/2026 | View on chart |
| DCI | ▼ Sell | Open Market | 6,600 | $589K | 4/14/2026 | View on chart |
| DCI | ▲ Buy | Option Exercise | 5,921 | $250K | 4/13/2026 | View on chart |
| DCI | ▼ Sell | Open Market | 5,921 | $527K | 4/13/2026 | View on chart |
| DCI | ▲ Buy | Option Exercise | 126 | $5K | 4/10/2026 | View on chart |
| DCI | ▼ Sell | Open Market | 126 | $11K | 4/10/2026 | View on chart |
| DCI | ▲ Buy | Grant | 279 | $24K | 4/3/2026 | View on chart |
| DCI | ▲ Buy | Grant | 900 | $0 | 1/2/2026 | View on chart |
| DCI | ▲ Buy | Grant | 250 | $22K | 1/2/2026 | View on chart |
| DCI | ▲ Buy | Grant | 272 | $22K | 10/3/2025 | View on chart |
| DCI | ▲ Buy | Grant | 316 | $23K | 7/7/2025 | View on chart |
| DCI | ▲ Buy | Option Exercise | 18,700 | $532K | 4/10/2025 | View on chart |
| DCI | ▼ Sell | Open Market | 18,700 | $1.2M | 4/10/2025 | View on chart |
| DCI | ▲ Buy | Grant | 370 | $23K | 4/4/2025 | View on chart |
| DCI | ▲ Buy | Grant | 334 | $22K | 1/2/2025 | View on chart |
| DCI | ▲ Buy | Grant | 1,300 | $0 | 1/2/2025 | View on chart |
| DCI | ▲ Buy | Grant | 305 | $22K | 10/4/2024 | View on chart |
| DCI | ▲ Buy | Option Exercise | 5,210 | $200K | 9/18/2024 | View on chart |
| DCI | ▼ Sell | Open Market | 5,210 | $374K | 9/18/2024 | View on chart |
| DCI | ▲ Buy | Option Exercise | 8,790 | $338K | 9/17/2024 | View on chart |
| DCI | ▼ Sell | Open Market | 8,790 | $637K | 9/17/2024 | View on chart |
| DCI | ▲ Buy | Grant | 321 | $22K | 7/5/2024 | View on chart |
| DCI | ▲ Buy | Grant | 302 | $22K | 4/5/2024 | View on chart |
| DCI | ▲ Buy | Grant | 289 | $19K | 1/2/2024 | View on chart |
| DCI | ▲ Buy | Grant | 1,200 | $0 | 1/2/2024 | View on chart |
| DCI | ▼ Sell | Open Market | 22 | $1K | 12/1/2023 | View on chart |
| DCI | ▲ Buy | Option Exercise | 11,400 | $491K | 11/30/2023 | View on chart |
| DCI | ▼ Sell | Open Market | 11,378 | $693K | 11/30/2023 | View on chart |
| DCI | ▲ Buy | Grant | 313 | $19K | 10/6/2023 | View on chart |
| DCI | ▲ Buy | Grant | 307 | $19K | 7/7/2023 | View on chart |
| DCI | ▲ Buy | Grant | 307 | $19K | 4/7/2023 | View on chart |
| DCI | ▲ Buy | Option Exercise | 10,800 | $383K | 3/2/2023 | View on chart |
| DCI | ▼ Sell | Open Market | 10,800 | $714K | 3/2/2023 | View on chart |
| DCI | ▲ Buy | Grant | 1,300 | $0 | 1/3/2023 | View on chart |
| DCI | ▲ Buy | Grant | 318 | $19K | 1/3/2023 | View on chart |
| FUL | ▼ Sell | Open Market | 64,689 | $4.9M | 11/11/2022 | View on chart |
| FUL | ▲ Buy | Option Exercise | 79,061 | $3.9M | 11/7/2022 | View on chart |
| FUL | ▼ Sell | Open Market | 79,061 | $5.6M | 11/7/2022 | View on chart |
| FUL | ▼ Sell | Open Market | 20,777 | $1.4M | 10/18/2022 | View on chart |
| DCI | ▲ Buy | Grant | 370 | $19K | 10/7/2022 | View on chart |
| FUL | ▲ Buy | Option Exercise | 40,348 | $1.6M | 8/8/2022 | View on chart |
| FUL | ▼ Sell | Open Market | 5,961 | $386K | 8/8/2022 | View on chart |
| FUL | ▼ Sell | Open Market | 34,387 | $2.2M | 8/8/2022 | View on chart |
| FUL | ▲ Buy | Option Exercise | 40,349 | $1.6M | 8/5/2022 | View on chart |
| FUL | ▼ Sell | Open Market | 40,349 | $2.6M | 8/5/2022 | View on chart |
| DCI | ▲ Buy | Grant | 386 | $19K | 7/1/2022 | View on chart |
| DCI | ▲ Buy | Grant | 355 | $19K | 4/1/2022 | View on chart |
| FUL | ▼ Sell | Tax Withholding | 2,248 | $160K | 1/27/2022 | View on chart |
| FUL | ▲ Buy | Option Exercise | 7,956 | $566K | 1/27/2022 | View on chart |
| FUL | ▲ Buy | Option Exercise | 8,579 | $626K | 1/24/2022 | View on chart |
| FUL | ▼ Sell | Tax Withholding | 1,521 | $111K | 1/24/2022 | View on chart |
| FUL | ▼ Sell | Tax Withholding | 2,473 | $180K | 1/24/2022 | View on chart |
| FUL | ▼ Sell | Tax Withholding | 2,765 | $202K | 1/24/2022 | View on chart |
| FUL | ▲ Buy | Grant | 4,968 | $362K | 1/24/2022 | View on chart |
| FUL | ▲ Buy | Option Exercise | 8,281 | $604K | 1/24/2022 | View on chart |
| DCI | ▲ Buy | Grant | 290 | $17K | 1/3/2022 | View on chart |
| DCI | ▲ Buy | Grant | 1,200 | $0 | 1/3/2022 | View on chart |
| FUL | ▼ Sell | Open Market | 10,000 | $736K | 11/30/2021 | View on chart |
| FUL | ▼ Sell | Open Market | 10,000 | $696K | 10/29/2021 | View on chart |
| FUL | ▼ Sell | Open Market | 5,000 | $331K | 9/30/2021 | View on chart |
| FUL | ▼ Sell | Open Market | 5,000 | $339K | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Morgan Stanley Raises DCI Target to $95 After Earnings Beat
Donaldson reported an earnings beat and announced a new share buyback plan, which has drawn positive attention from analysts. Morgan Stanley maintained its Equal-Weight rating but raised its price target to $95, reflecting confidence in the company's durable cash flow. The stock is currently trading near its 52-week low, a level where some analysts suggest it may be undervalued.
Morgan Stanley Raises DCI Target to $95 After Earnings Beat. Donaldson reported an earnings beat and announced a new share buyback plan, which has drawn positive attention from analysts. Morgan Stanley maintained its Equal-Weight rating but raised its price target to $95, reflecting confidence in the company's durable cash flow. The stock is currently trading near its 52-week low, a level where some analysts suggest it may be undervalued.